RWM
ABBV icon

Ritholtz Wealth Management’s AbbVie ABBV Stock Holding History

Ritholtz Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-400
Closed -$7K – 536
2021
Q1 		$7K Sell
400
-100
-20% -$10.7K ﹤0.01% 471
2020
Q4 		$7K Buy
+500
New +$48K ﹤0.01% 409

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ritholtz Wealth Management's ABBV Position: Q2 2026 in Review

Ritholtz Wealth Management increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $334K and bringing the position to 49,487 shares worth $12.5M. The position accounts for 0.19% of the portfolio, ranked #66.

Ritholtz Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ritholtz Wealth Management held 49,487 shares of AbbVie worth $12.5M as of Q2 2026.
  • Ritholtz Wealth Management bought 1,552 AbbVie shares in Q2 2026, an estimated $334K.
  • AbbVie made up 0.19% of Ritholtz Wealth Management's portfolio in Q2 2026, its #66 holding.
  • Ritholtz Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.